IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES

Latest POS EX SEC Filings
Post-effective amendment adding exhibits to registration statement [Rule 462(d)]

GENOME THERAPEUTICS CORP, POS EX, 2000-06-27


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission